Skip to main content
Figure 2 | Journal of Translational Medicine

Figure 2

From: Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer

Figure 2

Increased mRNA (Cohort I) and protein expression (Cohort II) of RBM3 are associated with a prolonged survival. Kaplan Meier analysis of recurrence free survival (A) and overall survival (B) according to RBM3 mRNA levels in Cohort I. Kaplan Meier analysis of overall survival according to immunohistochemical RBM3 staining in Cohort II in strata defined as (C) negative, intermediate and strong expression and (D) negative versus positive expression.

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us